NextGen BioMed 2025
12-14 March 2025 | Visit us at Booth #53
GenScript is excited to announce our presence at NextGen BioMed 2025, where we
will be showcasing our offerings at Booth #53. Join us at the Novotel West in London, UK, from March 12th to 14th, 2025.
Join the global hub for biologics innovation at NextGen BioMed 2025,
connecting pharmaceutical & biotech representatives as well as academia for high-level discussions on
bringing the next generation of biomedicines from concept to market.
From dynamic panels and expert-led workshops to unparalleled networking opportunities, NextGen BioMed 2025
offers everything you need to stay ahead in biologics R&D.
We are excited to meet you at Oxford Global´s premier event and share insights on how our
offerings can contribute to your success. Our team of experts will be available to answer your questions and
discuss the latest developments in protein & antibody engineering and our peptide & oligo options.
Come visit us at Booth #53, and let's explore the future of drug discovery &
development together!
Our Experts at NextGen BioMed 2025
Olivier Binggeli
Sales Leader
Nadine Stone
Sales Account Manager
Dean Cian
Sales Account Manager
George Buchanan
Sales Account Manager
Robert Ford
Field Application Scientist
Highlights
NextGen BioMed 2025 combines 6 cutting-edge programs into one event: Proteins, Antibodies & ADCs, Peptides, Oligonucleotides, Sustainability in Biologics & Tides as well as Immunotherapy & Immuno-Oncology and Vaccines.
Join us for our Workshop “Revolutionizing antibody development - from engineering to scientific breakthrough” that takes place on Wednesday, 12 of March 2025, from 12:05 – 13.45 in the Beaujolais Suite.
Our Speaker, Dr. Robert Ford, Field Application Scientist at GenScript Biotech, will discuss with us “AI-based methods for antibody therapeutic developability and engineering”, followed by a presentation from Dr. Jid Purohoo, Post Doctoral Research Associate at the Liverpool School of Tropical Medicine, “On the Use of IgG1 Fcs to inhibit IAV and IBV cell entry”. We will end this session with a case study on “Turbocharging bispecific antibody production” shared by Dr. Robert Ford and a lively discussion on challenges and opportunities in the antibody development field.
What's On at NextGen Biomed 2025?
GenScript is here to support your protein & antibody engineering journey and your peptide & oligo needs with cutting-edge solutions and expertise to advance your research and production goals.
GenScript - Your One-stop Solution
Most Popular Products
CRISPR Gene Editing
Antibodies
Protein Electrophoresis and Blotting
Molecular Biology
Stable Cell Lines
Cell Therapy
Diagnostics
Resources
